| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32bddc1ab8d6cf95c25c8ac2d52b6b82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86cc92217375e2002ab58b1c2a99c1cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17205ad18feb9be6cd65c2e68d8e0709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91e1034cddbaa981c8bca4112d82430f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-31 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate |
2022-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3befdf1548f4680e5c35912ef45b2f8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e5d87a4c60a8f60f17e9bb74531e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0e5389081e3cb2efa71a3c03efb755 |
| publicationDate |
2022-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022246240-A1 |
| titleOfInvention |
Skin care methods and formulations |
| abstract |
Described herein are formulations that comprise at least about 50% by weight water and no greater than about 1% by weight of a sphingolipid. The formulations can be applied to a region of skin of a subject. After the formulation is applied to the region of the skin of the subject, a biochemical pathway can be activated by the formulation to cause the production of a ceramide on the region of the skin of the subject. The amount of the ceramide produced on the region of the skin of the subject can be greater than a baseline amount of the ceramide that is produced in the absence of the formulation. In various examples, the increased amount of ceramide produced after applying the formulation to the region of the skin of the subject can modify a condition present on the region of the skin of the subject. |
| priorityDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |